Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Adv Gerontol ; 29(1): 102-106, 2016.
Article in Russian | MEDLINE | ID: mdl-28423254

ABSTRACT

The objective of the research was to study the effectiveness of the drug Cytoflavin in the comprehensive treatment of mixed form diabetic foot syndrome with media calcification arteries in 75 elderly patients with type 2 diabetes. Depending on the regimen, patients were divided into two groups: control received basic therapy; main group in addition to the base, received the drug Cytoflavin 10 ml 0,9 % NaCl 200 ml for 10 days, followed by a transition to the tablet form of the drug - 2 tablets 2 times per day orally for one month. The inclusion of the drug Cytoflavin in the treatment regimen increased the effectiveness of treatment, which was shown to improve tissue oxygenation due to the normalization of the basal oxygen tension, restoring the activity of antioxidant enzymes and, consequently, in an authentic decrease in the average time of hospital treatment and a decrease in the number of repeated surgical interventions and reamputatsy over the next year.


Subject(s)
Diabetic Foot , Aged , Antioxidants , Arteries , Diabetes Mellitus, Type 2 , Humans , Treatment Outcome
2.
Klin Khir ; (8): 15-7, 2014 Aug.
Article in Ukrainian | MEDLINE | ID: mdl-25417278

ABSTRACT

Conducted a comprehensive examination and surgical treatment for acute obstruction of the small intestine (SI). It is established that, both before and after surgery to restore patency of SI is a significant violation of the functional state of the liver. This became the basis for the appointment of antioxidant therapy in the complex standard treatment. Using the solution reamberin promotes effective correction protein syntesis function disorders of the liver, reduces the severity of inflammation and stagnation in the hepatocytes, the severity of endogenous intoxication and the incidence of postoperative complications.


Subject(s)
Antioxidants/therapeutic use , Intestinal Obstruction/physiopathology , Intestine, Small , Liver/physiopathology , Meglumine/analogs & derivatives , Succinates/therapeutic use , Adult , Aged , Aged, 80 and over , Antioxidants/administration & dosage , Female , Humans , Intestinal Obstruction/surgery , Intestine, Small/surgery , Liver/drug effects , Liver/metabolism , Liver Function Tests , Male , Meglumine/administration & dosage , Meglumine/therapeutic use , Middle Aged , Severity of Illness Index , Succinates/administration & dosage , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...